NEOPRO PAIN
Updated 318 days ago
3161 Elliott Ave Suite 308 Seattle, WA 98121
NeoPro Pain Inc. (NPP) is a development company focusing on the discovery of novel pharmaceutical agents for pain. NPP is a wholly owned subsidiary of NeoPro Labs, LLC (NPL). NPP's strategy is to complete the requirements of preclinical and clinical development for its drug candidate, EXIGALâ„¢ that represents a new class of pain relief medication for pain. The company is seeking to form strategic alliances and partnerships.
Also known as: NeoPro Labs, LLC, NeoPro Pain Inc.